kth.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Heparan Sulfate in Normal and Cancer Stem Cells of the Brain
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
KTH, School of Electrical Engineering and Computer Science (EECS), Intelligent systems.
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, UK.
2021 (English)In: Biology of Extracellular Matrix, Springer Science and Business Media Deutschland GmbH , 2021, Vol. 9, p. 205-236Chapter in book (Refereed)
Abstract [en]

Proteoglycans are key molecules in signaling, both during brain development and in malignant brain tumor formation, where cancer cells mimic, or co-opt, normal developmental programs. This chapter focuses on the role of heparan sulfate proteoglycans (HSPGs) in these processes. HSPGs are composed of a core protein with attached, heavily sulfated, polysaccharide side chains, and they are ubiquitously present on cell surfaces and in the extracellular space where they serve both as structural components and regulators of a multitude of cellular activities. HSPGs are critically involved in mammalian development, and perturbations of pathways regulated by HSPGs play major roles in human diseases. Neural stem cell programs sustain populations of stem cells that initially give rise to neural progenitors with high proliferative capacity that eventually differentiate to mature cells of the nervous system. HSPGs act as coreceptors for a wide variety of signaling pathways during these processes. Accumulated mutations in neural stem cells can cause failure to perform terminal differentiation or the inability to restrict progenitor proliferation and lead to brain tumor development. The same signaling mechanisms that promote self-renewal of neural stem cells thus also support cancer stem cells, and HSPGs are integral facilitators of brain tumor development and progression.

Place, publisher, year, edition, pages
Springer Science and Business Media Deutschland GmbH , 2021. Vol. 9, p. 205-236
Keywords [en]
Extracellular matrix, Glioblastoma, Medulloblastoma, Neural stem cell, Proteoglycan, Stem cell niche
National Category
Cell and Molecular Biology
Identifiers
URN: urn:nbn:se:kth:diva-348272DOI: 10.1007/978-3-030-73453-4_9Scopus ID: 2-s2.0-85195513637OAI: oai:DiVA.org:kth-348272DiVA, id: diva2:1874639
Note

QC 20240625

Available from: 2024-06-20 Created: 2024-06-20 Last updated: 2024-06-25Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Spyrou, Argyris

Search in DiVA

By author/editor
Spyrou, Argyris
By organisation
Intelligent systems
Cell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 34 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf